Overview Financials News + Filings Key Docs Charts Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Appointed CFO
Quarterly results
Acq. announced
Director departure
CC transcript
|
|
ACHIEVE LIFE SCIENCES, INC. (ACHV)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 06/02/2023 |
SC 13G/A
| Contrarian Alpha, LP reports a 9.7% stake in Achieve Life Sciences, Inc. |
| 02/13/2023 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/10/2023 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 11/22/2022 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/14/2022 |
SC 13G/A
| Francis Capital Management, LLC reports a 6.3% stake in Achieve Life Sciences, Inc. |
| 02/16/2021 |
SC 13G/A
| PURA VIDA INVESTMENTS, LLC reports a 1.4% stake in Achieve Life Sciences, Inc. |
| 02/16/2021 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/16/2021 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/12/2021 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/14/2020 |
SC 13G/A
| Sio Capital Management, LLC reports a 0% stake in Achieve Life Sciences, Inc. |
| 02/14/2020 |
SC 13G/A
| ARMISTICE CAPITAL, LLC reports a 5% stake in Achieve Life Sciences, Inc. |
| 02/11/2020 |
SC 13G/A
| UBS Group AG reports a 5% stake in Achieve Life Sciences, Inc. |
| 02/10/2020 |
SC 13G/A
| CVI Investments, Inc. reports a 9% stake in Achieve Life Sciences, Inc. |
| 09/12/2019 |
SC 13G/A
| Adamas Health Care Fund reports a 4.8% stake in Achieve Life Sciences, Inc. |
| 06/13/2019 |
SC 13G/A
| ARMISTICE CAPITAL, LLC reports a 8% stake in Achieve Life Sciences, Inc. |
| 06/07/2019 |
SC 13G/A
| ARMISTICE CAPITAL, LLC reports a 13.7% stake in Achieve Life Sciences, Inc. |
| 05/15/2019 |
SC 13G/A
| HIRSCHMAN ORIN reports a 5% stake in Achieve Life Sciences, Inc. |
| 02/15/2019 |
SC 13G/A
| HIRSCHMAN ORIN reports a 6.1% stake in Achieve Life Sciences, Inc. |
| 02/14/2019 |
SC 13G/A
| ARMISTICE CAPITAL, LLC reports a 6.7% stake in Achieve Life Sciences, Inc. |
| 01/04/2019 |
SC 13G/A
| SABBY MANAGEMENT, LLC reports a 0.2% stake in Achieve Life Sciences, Inc. |
| 02/14/2017 |
SC 13G/A
| H.I.G. ONCOGENEX, INC. reports a 0% stake in OncoGenex Pharmaceuticals, Inc. |
| 02/16/2016 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 06/10/2013 |
SC 13G/A
| ONCOGENEX PHARMACEUTICALS, INC. reports a 4.4% stake in ONCOGENEX PHARMACEUTICAL INC |
| 02/11/2013 |
SC 13G/A
| Abingworth LLP reports a 4.1% stake in OncoGenex Pharmaceuticals, Inc. |
| 02/14/2012 |
SC 13G/A
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals [amend] |
| 02/14/2012 |
SC 13G/A
| ONCOGENEX PHARMACEUTICALS, INC. reports a 5.6% stake in OncoGenex Pharmaceuticals, Inc. |
| 02/14/2012 |
SC 13G/A
| Boxer Capital, LLC reports a 6.4% stake in OncoGenex Pharmaceuticals, Inc. |
| 02/14/2012 |
SC 13G/A
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals [amend] |
| 02/07/2012 |
SC 13G/A
| ONCOGENEX PHARMACEUTICALS, INC. reports a 6.2% stake in OncoGenex Pharmaceuticals, Inc. |
| 02/11/2011 |
SC 13G/A
| H.I.G. ONCOGENEX, INC. has filed a Schedule 13D for OncoGenex Pharmaceuticals, Inc. |
| 11/01/2010 |
SC 13G/A
| ONCOGENEX PHARMACEUTICALS, INC. has filed a Schedule 13D for OncoGenex Pharmaceuticals, Inc. |
| 02/16/2010 |
SC 13G/A
| ONCOGENEX PHARMACEUTICALS, INC. has filed a Schedule 13D for OncoGenex Pharmaceuticals, Inc. |
| 02/16/2010 |
SC 13G/A
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals [amend] |
| 02/12/2010 |
SC 13G/A
| ONCOGENEX PHARMACEUTICALS, INC. has filed a Schedule 13D for OncoGenex Pharmaceuticals, Inc. |
|
|
|